Tirzepatide can cost $500 to $1,900 a month without insurance. More affordable tirzepatide alternatives include semaglutide, ...

The Wegovy pill is expected to hit the market in January, joining injectable GLP-1 drugs that have transformed obesity treatment. One form you swallow, the other you inject. What else is different?

Most experts agree that 4 to 8 pounds per month, or 1 to 2 pounds per week, is a realistic and healthy weight loss goal for most people. How quickly you lose weight depends on several factors. The key ...

Many people want to lose a lot of weight quickly, and on the surface, losing 30 pounds in three months may sound achievable with enough willpower. But even if its possible, its not always safe or ...

At the end of the day, GLP-1s can be a powerful tool for achieving your weight loss goals, but only if they're safe and ...

On average, Mochi Health members lose 36 pounds in their first year, and most sustain their weight loss much longer than they ...

A pill version of the GLP-1 weight-loss drug Wegovy is expected to debut in the U.S. in early January. But how will the pills ...

Daily weight fluctuations are normal and shouldn't discourage weight loss efforts. The body stores energy as fat and glycogen, with glycogen levels changing more readily. Weighing yourself every few ...

The drugs' high prices, along with spotty insurance coverage, have left them out of reach for many Americans. Read more at ...

Nearly half of seniors quit GLP-1 weight-loss drugs within a year. Experts reveal why older Americans abandon medications like Ozempic and Wegovy despite results.

The FDA approved the first-ever GLP-1 weight-loss pill, a once-daily semaglutide tablet from Novo Nordisk, launching in the U ...

Low-income Californians who use Wegovy and similar weight loss drugs will lose their coverage in January. California and ...